Studienübersicht zur Wirksamkeit
und Sicherheit von Nerivio®
In den Placebo-kontrollierten Studien wurde Nerivio® mit einem Sham-Gerät
(einem optisch vergleichbaren Gerät ohne wirksame neuronale Impulse) verglichen.
Randomisiert kontrollierte Studie vs. Placebo
Blumenfeld AM et al. Pain Management. 2023;13(8):425–432.
Temporal analysis of remote electric neuromodulation for the prevention of migraine.
Tepper SJ et al. Headache. 2023; 63(3):377–389.
Remote electrical neuromodulation for migraine prevention: A double-blind, randomized, placebo-controlled clinical trial.
Yarnitsky D et al. Headache. 2019;59(8): 1240–1252.
Remote electrical neuromodulation (REN) relieves acute migraine: A randomized, double-blind, placebo-controlled, multicenter trial.
Yarnitsky D et al. Neurology. 2017; 88(13):1250–1255.
Nonpainful remote electrical stimulation alleviates episodic migraine pain.
Crossover-Vergleiche mit Standard-Medikamenten
Grosberg B et al. Pain Manag. 2022; 12(7):837–844.
Effectiveness comparison of remote electrical neuromodulation and standard-care medications for acute treatment of chronic migraine: a post-hoc analysis.
Hershey AD et al. Pain Medicine. 2022; 23(4):815–820.
Comparison of remote electrical neuromodulation and standard-care medications for acute treatment of migraine in adolescents: A post-hoc analysis.
Rapoport AM et al. J Headache Pain. 2019; 20(1):83
Remote electrical neuromodulation (REN) in the acute treatment of migraine: a comparison with usual care and acute migraine medications.
Studien in spezifischen Populationen
Werner K et al. Annals of CNS. 2024; 2(2):135–145.
Acute treatment of migraine in children aged 6−11: Real-world analysis of remote electrical neuromodulation (REN).
Peretz A et al. Headache. 2023; 63(7):968–970.
Safety of remote electrical neuromodulation for acute migraine treatment in pregnant women: A retrospective controlled survey-study.
Grosberg B et al. Pain Reports. 2021; 8(4):e966.
Safety and efficacy of remote electrical neuromodulation for the acute treatment of chronic migraine: an open-label study.
Nierenburg H et al. Pain Ther. 2021; 10(2):1245–1253.
Remote electrical neuromodulation (REN) for the acute treatment of menstrual migraine: a retrospective survey study of effectiveness and tolerability.
Hershey AD et al. Headache. 2021; 61(2):310–317.
Remote electrical neuromodulation for acute treatment of migraine in adolescents.
Nierenburg H et al. Pain Therapy. 2020; 9(2):531–543.
Remote electrical neuromodulation for the acute treatment of migraine in patients with chronic migraine: An open-label pilot study.
Real-World-Evidence (RWE)-Studien
Synowiec A et al. Adv Ther. 2024; 41(1):170–181.
One-year consistent safety, utilization, and efficacy assessment of remote electrical neuromodulation (REN) for migraine treatment.
Monteith TS et al. Front Pain Research. 2023; 4:1247313.
Remote electrical neuromodulation (REN) wearable device for adolescents with migraine: a real-world study of high-frequency abortive treatment suggests preventive effects.
Esparham A et al. Pediatr Neurol. 2023; 142:51–55.
Acute treatment of migraine in adolescents: Real-world analysis of remote electrical neuromodulation (REN).
Ailani J et al. Front Pain Res. 2022; 18:753736.
Real-world analysis of remote electrical neuromodulation (REN) for the acute treatment of migraine.
Buse DC et al. Pain Med. 2022; 23(9):1544–1549.
Combining guided intervention of education and relaxation (GIER) with remote electrical neuromodulation (REN) in the acute treatment of migraine.
Tepper SJ et al. Pain Med. 2020; 21(12):3522–3529.
Real-world experience with remote electrical neuromodulation in the acute treatment of migraine.
HEOR Studien
Cowan R et al. J Med Econ. 2023; 26(1):656–664.
Clinical benefits and economic cost-savings of remote electrical neuromodulation (REN) for migraine prevention.
Marmura MJ et al. Front Neurology. 2020; 11:226.
Incorporating remote electrical neuromodulation (REN) into usual care reduces acute migraine medication use: An open-label extension study.
Zur Studiendatenbank von Theranica (Englisch)
Weitere Informationen über Nerivio®
Kontakt
Bei Fragen schreiben Sie uns bitte eine Nachricht über das Kontaktformular.
Nerivio® verschreiben
Nur mit Privatrezept – wie bekommen Ihre Patienten das Nerivio®-Armband?

